๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)
NCT07513233Acute Ischemic Stroke
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
NCT07450599High-risk Localized Prostate Cancer
Bayer
Phase 2
250
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Shijiazhuang, Harbin, Zhengzhou
2026-04-27
Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NCT07557225Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer
Peking University First Hospital
Not applicable
200
Beijing
2026-04-27
Not yet open
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy
NCT07493057Obstructive Sleep Apnea (OSA)
Gan & Lee Pharmaceuticals.
Phase 3
140
Beijing
2026-04-27
Recruiting
Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study
NCT07440537Cutaneous Lupus Erythematosus (CLE)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
105
Hefei, Beijing, Chongqing, Fuzhou, Dongguan, Guangzhou, Shijiazhuang, Zhengzhou
2026-04-27
Not yet open
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis๏ผˆECHO-TAVR๏ผ‰
NCT07317804Aortic Stenosis, TAVI, TAVI(Transcatheter Aortic Valve Implantation)
China National Center for Cardiovascular Diseases
Phase 4
212
Beijing
2026-04-26
Recruiting
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
NCT07439445Helicobacter Pylori Infection
Peking University First Hospital
Not applicable
70
Beijing
2026-04-25
Recruiting
Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
NCT07670286Pancreatic Cancer, Cachexia; Cancer; Sarcopenia
Peking Union Medical College Hospital
Observational
500
Beijing
2026-04-24
Recruiting
A Novel Two-Tooth Clip for ESD and EFTR of GIST
NCT07581977GIST - Gastrointestinal Stromal Tumor
Affiliated Hospital to Academy of Military Medical Sciences
Not applicable
60
Beijing
2026-04-24
Recruiting
First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
NCT07332858Malignant Pleural Effusions (Mpe), Non Small Cell Lung Cancer
Gang Hou
Phase 1/2
105
Beijing
2026-04-24
Recruiting
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
NCT07520162Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca
Phase 3
230
Beijing, Bengbu, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Foshan
2026-04-24
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
NCT07419295Bladder Cancer
Merck Sharp & Dohme LLC
Phase 3
590
Beijing, Chongqing, Guangzhou, Zhuhai, Wuhan, Changsha, Nanjing, Nanchang
2026-04-23
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Recruiting
A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy
NCT07580703AD - Alzheimer's Disease, MCI
Eli Radiopharma
Phase 1
18
Beijing
2026-04-23
Recruiting
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
NCT07480733Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
410
Beijing
2026-04-23
Not yet open
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599Ischemic Cerebral Infarction
Beijing Tiantan Hospital
Phase 3
4,810
Fuyang, Wuhu, Beijing, Chongqing, Ningde, Dingxi, Jiuquan, Lanzhou
2026-04-22
Active, closed
Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations
NCT07338942ATTR-CM
AstraZeneca
Not applicable
4,000
Beijing, Changlexi, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangdong Province
2026-04-21
Recruiting
A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Solid Tumours.
NCT07648472Advanced Solid Tumors
Joint Biosciences Ltd.
Phase 1
18
Beijing
2026-04-21
Recruiting
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation
NCT07556068Acute Ischemic Stroke, Cerebral Autoregulation
Beijing Shijitan Hospital, Capital Medical University
Observational
129
Beijing, Harbin, Dalian, Weifang
2026-04-20
Not yet open
A Comparative Analysis of Mid- to Long-Term Outcomes: Paclitaxel-Coated Balloon With Debulking Versus Paclitaxel-Coated Balloon Alone in the Treatment of Chronic Femoropopliteal Artery Occlusions
NCT07406308Femoropopliteal Artery Occlusion
Peking Union Medical College Hospital
Phase EARLY_PHASE1
408
Beijing
2026-04-20
Recruiting
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
NCT07366112Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
Peking University People's Hospital
Phase 2
158
Beijing
2026-04-20
Recruiting
QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT07463573Esophageal Squamous Cell Carcinoma (ESCC)
Qilu Pharmaceutical Co., Ltd.
Phase 3
466
Beijing
2026-04-20
Not yet open
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT07583030Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD), Progressive Multiple Sclerosis (PMS), Relapsed/Refractory Myasthenia Gravis(r/r MS)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
44
Hefei, Beijing, Wuhan, Taiyuan
2026-04-20
Not yet open
Language Function Reorganization in Patients With Arteriovenous Malformations
NCT07537504Brain Arteriovenous Malformations
Beijing Tiantan Hospital
Observational
120
Beijing
2026-04-20
Recruiting
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
NCT07409181Systemic Lupus Erythematosus
Boehringer Ingelheim
Phase 2
405
Beijing, Changchun, Changsha, Guangzhou, Linfen, Nanjing, Ningbo, Shanghai
2026-04-20
Not yet open
Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes
NCT07520305Type 2 Diabetes
Beijing Chao Yang Hospital
Not applicable
70
Beijing
2026-04-20
Not yet open
Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients
NCT07536607Coronary Artery Disease
Chinese PLA General Hospital
Observational
180
Beijing
2026-04-20
Not yet open
Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With Connective Tissue Disease-related Interstitial Lung Disease
NCT07495033CTD-ILD
RemeGen Co., Ltd.
Phase 3
260
Beijing
2026-04-20
Active, closed
Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)
NCT07551505Dyslipidemias
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 1
40
Beijing
2026-04-20
Recruiting
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC
NCT07416695SCLC, NEC
Shanghai Henlius Biotech
Phase 1
138
Beijing, Shanghai
2026-04-17
Recruiting
IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07483567CLDN18.2 Positive, Primary Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
90
Beijing
2026-04-17
Not yet open
Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life
NCT07532421Antibiotic, Allergic Diseases, Infants, Probiotic
Peking University Third Hospital
Not applicable
400
Beijing
2026-04-17
Recruiting
A Retrospective Analysis of Patients With Gastroesophageal Reflux Disease Based on a Prospective Clinical Dataset
NCT07749989Gastroesophageal Reflux Disease
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-04-17
Recruiting
A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China
NCT07588880Progressive Familial Intrahepatic Cholestasis
Ipsen
Observational
20
Beijing, Chongqing, Hunan, Nanjing, Shanghai, Xiamen
2026-04-16
Recruiting
Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer
NCT07704177Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-15
Recruiting
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT07385703Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
752
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-04-15
Not yet open
The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device
NCT07514949Stroke, Acute Ischemic Stroke, Blood-Brain Barrier
yilong Wang
Not applicable
6
Beijing
2026-04-15
Recruiting
VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial
NCT07514832AML (Acute Myeloid Leukemia)
Beijing 302 Hospital
Phase 2
48
Beijing
2026-04-15
Not yet open
A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Replacement for Type-0 Bicuspid Aortic Valve Stenosis Patients in China
NCT07450196Aortic Stenosis, AORTIC VALVE DISEASES
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
170
Beijing
2026-04-15
Recruiting
Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis
NCT07542938Symptomatic Intracranial Atherosclerotic Stenosis
Xuanwu Hospital, Beijing
Not applicable
264
Beijing, Fuzhou, Shijiazhuang, Harbin, Nanyang, Zhengzhou, Baotou, Xi'an
2026-04-15
Recruiting
Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
NCT07511582Sepsis, Acute Respiratory Distress Syndrome
Bin Du
Phase 2
150
Beijing
2026-04-15
Recruiting
Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II
NCT07396077Spine Degeneration, Lumbar Degenerative Disease, Frail Elderly, Enhanced Recovery After Surgery (ERAS) Protocol
Xuanwu Hospital, Beijing
Not applicable
248
Beijing
2026-04-15
Active, closed
AI-Assisted Mindfulness Intervention in Emotional Distress
NCT07542561Subclinical Depression, Subclinical Anxious Adults, Subclinical Emotional Distress
Xinghua Liu
Not applicable
550
Beijing
2026-04-15
Recruiting
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
NCT07533006Alopecia Areata
Eli Lilly and Company
Phase 2
60
Beijing, Shanghai, Tianjin
2026-04-14
Recruiting
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07493135Relapsed/Refractory Multiple Myeloma
Suzhou Immunofoco Biotechnology Co., Ltd
Phase EARLY_PHASE1
30
Beijing, Chongqing, Shanghai, Zhengzhou
2026-04-14
Recruiting
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
NCT07525986Laparoscopic Surgery, Visceral Pain, Postoperative, Anrikefon, Patient-controlled Intravenous Analgesia
Peking University First Hospital
Phase 4
140
Beijing
2026-04-14
Recruiting
Efavirenz for the Treatment of Creutzfeldt-Jakob Disease
NCT07482085Creutzfeldt-Jakob Disease
Xuanwu Hospital, Beijing
Phase 3
246
Beijing
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
Eli Lilly and Company
Phase 2
66
Beijing, Hangzhou, Shanghai, Shenzhen
2026-04-14
Recruiting
Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors
NCT07529002Solid Tumors
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2026-04-14
Recruiting
CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms
NCT07416682High-risk Plasma Cell Neoplasms
Affiliated Hospital to Academy of Military Medical Sciences
Phase EARLY_PHASE1
20
Beijing
2026-04-14
Recruiting
DAREON ยฎ -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim
Phase 3
670
Beijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2026-04-13
Recruiting
A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism
NCT07540286Hypoparathyroidism
Peking Union Medical College Hospital
Phase 2
60
Beijing
2026-04-13
Recruiting
AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma
NCT07538882Hepatocellular Carcinoma (HCC)
Beijing Tsinghua Chang Gung Hospital
Observational
108
Beijing
2026-04-13
Recruiting
Expression of Target in Endometriotic Lesions
NCT07693283Endometriosis
Beijing Tsinghua Chang Gung Hospital
Observational
40
Beijing
2026-04-13
Recruiting
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors
NCT07414836Advanced Solid Tumor
BeOne Medicines
Phase 1
84
Beijing, Chongqing, Fuzhou, Guangzhou, Yichang, Shanghai
2026-04-13
Recruiting
A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
NCT07390383Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd
Phase 2
110
Beijing, Shijiazhuang, Jinan, Qingdao, Taiyuan, Tianjin
2026-04-13
Recruiting
A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT07484724Advanced Esophageal Squamous Cell Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
280
Beijing
2026-04-13
Not yet open
Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
NCT07387003Type 2 Diabetes (T2DM)
Gan & Lee Pharmaceuticals.
Phase 2
345
Beijing
2026-04-10
Recruiting
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
NCT07724847Axial Spondyloarthritis (AxSpA), Spondyloarthritis (SpA), Chronic Back Pain
Chinese PLA General Hospital
Observational
247
Beijing
2026-04-10
Recruiting
A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus
NCT07405970Systemic Lupus Erythematosus
Beijing Mabworks Biotech Co., Ltd.
Phase 3
316
Beijing
2026-04-10
Recruiting
Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness
NCT07571226Major Depressive Disorder (MDD), Anxiety Disorder, Alcohol Use Disorder (AUD)
Huashan Hospital
Observational
680
Beijing, Shanghai
2026-04-10
Recruiting
Efficacy of Bright Light Therapy on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms: Protocol for a Randomised Controlled Trial
NCT07508215Major Depressive Disorder (MDD), Neuroimaging, Bright Light Treatment, Cognitive Impairment
Peking University Sixth Hospital
Not applicable
120
Beijing, Yanan
2026-04-10
Recruiting
FAPl Imaging Assessment of Revascularization Outcome in Ischemic Heart Failure
NCT07657650Ischemic Heart Failure
Beijing Chao Yang Hospital
Observational
122
Beijing
2026-04-10
By invitation
A Post-marketing Observational Study of Oral Cholera Vaccine
NCT07300462Diarrhea
Shanghai United Cell Biotechnology Co., Ltd
Phase 4
6,000
Hefei, Beijing, Wuhan, Nanjing, Jinan
2026-04-10
Not yet open
Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy
NCT07518810Multiple System Atrophy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2/3
150
Nanning, Huzhou, Jiaxing, Ningbo, Taizhou, Beijing
2026-04-10
Not yet open
Effect of tNGS on CAP Patients With Initial Treatment Failure
NCT07472114Community Acquired Pneumonia (CAP)
Capital Medical University
Not applicable
524
Beijing
2026-04-10
Recruiting
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
NCT07479485Hepatocellular Carcinoma
Lepu Biopharma Co., Ltd.
Phase 1/2
160
Beijing, Fuzhou, Zhengzhou, Nanjing, Tianjin, Lishui
2026-04-08
Recruiting
Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients
NCT07479602Adenotonsillectomy, Children, Intranasal Administration, Dexmedetomidine
Peking University First Hospital
Phase 4
160
Beijing
2026-04-07
Recruiting
Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
NCT07629596Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia (AIHA)
Circunited BioPharma (Shenzhen) Co., Ltd.
Phase EARLY_PHASE1
5
Beijing
2026-04-07
Recruiting
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
NCT07527078Type 2 Diabetes (T2DM)
Gan & Lee Pharmaceuticals.
Phase 3
350
Beijing
2026-04-07
Recruiting
Phase โ…ข Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
NCT07390123IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
370
Huangshan City, Wuhu, Beijing, Zhanjiang, Changsha, Changchun, Linyi, Shanghai
2026-04-07
Recruiting
Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
NCT07635394Irritable Bowel Syndrome (IBS)
Beijing Tiantan Hospital
Not applicable
258
Beijing
2026-04-07
Recruiting
Dexamethasone Palmitate for Postoperative Pain
NCT07341854Pain, Postoperative, Dexamethasone Palmitate
Beijing Tiantan Hospital
Not applicable
446
Beijing
2026-04-06
Recruiting
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
NCT07416474Non-Small Cell Lung Cancer
RemeGen Co., Ltd.
Phase 3
574
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Dongguan, Guangzhou
2026-04-03
Recruiting
A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus
NCT07299422Systemic Lupus Erythematosus
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
248
Beijing, Shanghai
2026-04-03
Recruiting
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
NCT07428499Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE
ADARx Pharmaceuticals, Inc.
Phase 3
90
Beijing, Harbin, Zhengzhou
2026-04-02
Not yet open
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation
NCT06986434Relapsed or Refractory Plasma Cell Neoplasms, Lymphomas/Leukemias With Plasmacytic Differentiation
Affiliated Hospital to Academy of Military Medical Sciences
Phase EARLY_PHASE1
20
Beijing
2026-04-02
Recruiting
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
NCT07338175Intracerebral Hemorrhage
Beijing Tiantan Hospital
Phase 3
1,192
Beijing, Chongqing, Guangzhou, Baoding, Zhangjiakou, Zunhua, Mengzhou, Nanle
2026-04-02
Recruiting
Grid eXplore Mapping Study
NCT07421076Paroxysmal Atrial Fibrillation (PAF)
Abbott Medical Devices
Not applicable
200
Jinan, Chengdu, Hangzhou, Ningbo, Beijing
2026-04-02
Recruiting
A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV
NCT07445893Polycythemia Vera (PV)
Duan Minghui
Not applicable
30
Beijing
2026-04-02
Recruiting
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
NCT07548177Alveolar Soft Part Sarcoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
33
Beijing, Chongqing, Guangdong, Harbin, Zhengzhou, Wuhan, Changsha, Changchun
2026-04-02
Not yet open
Auricular Acupressure for Reducing Postoperative Emergence Agitation in Preschool Children
NCT07472764Emergence Agitation
Beijing Tongren Hospital
Not applicable
110
Beijing
2026-04-01
Not yet open
Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma
NCT07504939Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy, Upper Tract Urothelial Carcinoma
Peking University First Hospital
Observational
36
Beijing
2026-04-01
Not yet open
Safety and Efficacy of Conscious Sedation Versus General Anesthesia in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation
NCT07541339Atrial Fibrillation (Paroxysmal)
Beijing Anzhen Hospital
Not applicable
224
Beijing
2026-04-01
Recruiting
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
NCT07774533Osteosarcoma, Osteosarcoma, Recurrent, Refractory
Peking University First Hospital
Phase EARLY_PHASE1
16
Beijing
2026-04-01
Not yet open
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
NCT07451665Takayasu Arteritis (TAK)
Chinese SLE Treatment And Research Group
Phase 4
180
Beijing, Guanzhou, Shenzhen, Nanning, Jiaozuo, Luoyang, Wuhan, Nanjing
2026-04-01
Not yet open
Darolutamide ยฑ ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer
NCT07476677Prostate Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
60
Beijing
2026-04-01
Recruiting
GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.
NCT07407504Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
186
Beijing
2026-04-01
Not yet open
Integrated Rehabilitation in HDU for Post-Intensive Care SyndromeLiberation in Patients With PICS
NCT07521540Post-Intensive Care Syndrome (PICS), Critical Illness Recovery, Mechanical Ventilation
Hongying Jiang, MD
Not applicable
250
Beijing
2026-04-01
Not yet open
Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy
NCT07370116Pancreaticoduodenectomy, Nasogastric Tube Decompression, Minimally Invasive Surgical Procedures
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
200
Beijing
2026-04-01
By invitation
cRCT of AI Agent in Clinital Resoning Training
NCT07624682Medical Education, Clinical Reasoning, AI Agent
Peking Union Medical College Hospital
Not applicable
88
Beijing
2026-04-01
Recruiting
Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)
NCT07525466Extranodal NK T Cell Lymphoma, Hemophagocytic Lymphohistiocytosis (HLH)
Beijing Tongren Hospital
Phase 1/2
25
Beijing
2026-04-01
Not yet open
Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis
NCT07495150Blood-Brain Barrier, Bacterial Meningitis
yilong Wang
Not applicable
86
Beijing, Kaifeng, Xinxiang, Zhengzhou, Linyi, Tianjin
2026-04-01
Recruiting
CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy
NCT07779018Lymphoma
Liping Dou
Phase 2
30
Beijing
2026-04-01
Not yet open
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
NCT07256197Aortic Stenosis, Calcific
Beijing Anzhen Hospital
Phase 3
160
Beijing
2026-04-01
Not yet open
Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy
NCT07400250Primary Immune Thrombocytopenia (ITP)
Peking Union Medical College Hospital
Phase 2
28
Beijing
2026-04-01
Recruiting
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
NCT07523737Primary Central Nervous System Lymphoma (PCNSL), Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital
Phase 2
43
Beijing
2026-04-01
Recruiting
Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study
NCT07295821Lung Cancer
AstraZeneca
Phase 2
60
Beijing, Changchun, Changsha, Chengdu, Foshan, Fuzhou, Guangzhou, Harbin
2026-04-01
Not yet open
A Multicenter, Prospective, Randomized Controlled Study Comparing Glucocorticoid Combined With Sirolimus With Monotherapy of Glucocorticoid in the Treatment of Newly Diagnosed Mild Autoimmune Hemolytic Anemia
NCT07518277Autoimmune Hemolytic Anemia (AIHA)
Chen Miao
Not applicable
216
Beijing
2026-04-01
Not yet open
Randomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion๏ผˆREPAIR๏ผ‰
NCT07495969Symptomatic Non-acute Intracranial Artery Occlusion, Ischemic Stroke
Feng Gao
Not applicable
286
Beijing
2026-04-01
Rows per page Showing 701–800 of 5484
Previous 6 7 8 9 10 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=8

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.